EYPT - EyePoint Pharmaceuticals Inc. (EYPT) CEO Nancy Lurker on Q3 2021 Results - Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2021 Earnings Conference Call November 03, 2021 08:30 A.M. ET Company Participants George O. Elston - CFO & Head, Corporate Development Nancy Lurker - President & CEO Jay Duker - COO Scott Jones - Chief Commercial Officer Conference Call Participants Unidentified Analyst - Cowen and Company Jennifer Kim - Cantor Fitzgerald Yatin Suneja - Guggenheim Partners Yale Jen - Laidlaw & Company Yi Chen - H.C. Wainwright Presentation Operator Good day and thank you for standing by. Welcome to the EyePoint Third Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers presentation there will a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded. [Operator Instructions]. I would now like to hand the conference over to your speaker today, George Elston, Chief Financial Officer. Please go ahead. George O. Elston Thank
For further details see:
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2021 Results - Earnings Call Transcript